New York, NY -- (SBWIRE) -- 09/16/2013 -- StockMarketIntel.com issues a special report on the following stocks: Real Goods Solar, Inc. (NASDAQ:RSOL), DURECT Corporation (NASDAQ:DRRX), Oi SA (ADR) (NYSE:OIBR), Inovio Pharmaceuticals Inc (NYSEMKT:INO)
Real Goods Solar, Inc. (NASDAQ:RSOL)’s number of shares traded in the last trading day were 3.93 million, on the other hand, its average trading volume was 1.22million shares. In prior session, the stock advanced +7.21%and closed the trading activity at $2.38. Watching the stock’s previous 5 day trend, the stock showed a bullish move of +20.81%. Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It provides commercial and residential solar energy solutions.
What RSOL’s Charts Are Signaling for Traders? Find Out Here
DURECT Corporation (NASDAQ:DRRX) opened the most recent session at the price of $1.39. Its previous closing price was recorded at $1.42. DURECT Corporation (NASDAQ:DRRX) gained +5.97%and traded within the range of $1.37- $1.45 in prior trading activity. The 52 week range of the stock remained in between $0.61- $1.85. Total volume of the stock was 2.39 million shares during last trade, while its average volume remained 697,481 shares. DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms.
Should DRRX a Buy or Sell Now? Find Out Here
Oi SA (ADR) (NYSE:OIBR) surged +5.85% and finished the trading at $1.81. Yesterday’s price range of OIBR was $1.69- $1.81, while the market capitalization of the stock was 2.97 billion. The stock traded with volume of 5 million shares in preceding session, as compared to average volume of 3.83 million shares. Oi S.A., through its subsidiaries, provides integrated telecommunication services for residential customers, companies, and governmental agencies in Brazil.
Where OIBR is Headed Exactly? Find out in This Trend Analysis Reports
Inovio Pharmaceuticals Inc (NYSEMKT:INO), in preceding trading session, showed a bullish movement of +5.38% and remained with market capitalization of 446.27 million. The stock gained volume of 9.36million shares in prior session, while the average volume was 13.03 million shares. The YTD trend of the stock remained positive +384.34%. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases.
Can INO Show a Strong Recovery? Find out in This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)